UK markets close in 6 hours 59 minutes

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
3.8900+0.0400 (+1.04%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,038
7,038
189,556
9,330
9,344
Operating expenses
Research development
48,784
48,784
50,749
55,718
56,075
Selling general and administrative
18,995
18,995
21,822
16,906
11,027
Total operating expenses
68,146
68,146
72,943
72,749
67,670
Operating income or loss
-61,108
-61,108
116,613
-63,419
-58,326
Interest expense
34
34
605
548
295
Total other income/expenses net
-5,106
-5,106
717
92
-4,512
Income before tax
-61,984
-61,984
117,853
-63,783
-62,775
Income tax expense
0
0
0
2
-11
Income from continuing operations
-61,984
-61,984
117,853
-63,785
-62,764
Net income
-61,984
-61,984
117,853
-63,785
-62,764
Net income available to common shareholders
-61,984
-61,984
117,853
-63,785
-62,764
Basic EPS
-1.83
-
3.63
-2.06
-2.51
Diluted EPS
-1.83
-
3.54
-2.06
-2.51
Basic average shares
32,693
-
32,470
31,005
25,001
Diluted average shares
32,942
-
33,266
31,005
25,001